Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03645031 · ClinicalTrials.gov registry record · NA
Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03645031 is a NA study that has completed, run by University of Florida. The registered enrollment target is 29 participants.
The verdict
NCT03645031, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This project seeks to investigate the effects of a single acute intermittent hypoxia (AIH) session on respiratory and non-respiratory motor function and EMG (electromyography) activity on patients with ALS (amyotrophic lateral sclerosis) and healthy controls.
Interventions
- OTHER Acute Intermittent Hypoxia
- OTHER Sham Acute Intermittent Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2023-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03645031
The ClinicalTrials.gov registry entry for NCT03645031 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acute Intermittent Hypoxia is the first listed.
NCT03645031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03645031 about?
NCT03645031 is a clinical study titled "Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease". This project seeks to investigate the effects of a single acute intermittent hypoxia (AIH) session on respiratory and non-respiratory motor function and EMG (electromyography) activity on patients with ALS (amyotrophic lateral sclerosis) and healthy controls.
What is the current status of trial NCT03645031?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-10-01. Estimated completion is 2023-06-02.
What interventions are being tested in trial NCT03645031?
The interventions under investigation include: Acute Intermittent Hypoxia (OTHER), Sham Acute Intermittent Hypoxia (OTHER).
Who is sponsoring clinical trial NCT03645031?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.